Form 4: OPKO Health Vice Chairman & CTO, Jane Hsiao, Reports Acquisition of 500,000 Shares
SEC Form 4 Filing
Jane Hsiao, Vice Chairman & CTO of OPKO Health, reports acquiring 500,000 shares of common stock on July 24, 2024.
Summary
- On July 24, 2024, Jane Hsiao, the Vice Chairman & CTO of OPKO Health, acquired 500,000 shares of OPKO common stock.
- The acquisition was made at a price of $0.00 per share.
- Following the transaction, Dr. Hsiao directly owns 28,499,880 shares of OPKO common stock.
- Dr. Hsiao also indirectly owns 5,127,404 shares through Hsu Gamma Investment, L.P., where she serves as the general partner.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing indicating insider trading activity. The acquisition itself could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.
Positives
- The acquisition of a significant number of shares by a high-ranking executive could be interpreted positively by the market, signaling confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 07/24/2024 | Date of the stock acquisition transaction. |
| 07/26/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.